PDS Biotechnology (FRA:EU6) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EU6 PDS Biotechnology Corp FRA:EU6
26 GF Score
Price €0.70
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:EU6
26GF Score
PDS Biotechnology Corp FRA:EU6
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp is a clinical-stage immunotherapy company based in the United States. It develops targeted cancer treatments built on its proprietary Versamune platform, a lipid-based nanoparticle technology designed to activate and direct the immune system against cancer cells. The company is advancing a pipeline of product candidates, including PDS0101, being studied in HPV-associated cancers such as head and neck, cervical, and anal cancer, often in combination with other immunotherapies and standard treatments. It also pursues infectious disease applications of the platform. As a clinical-stage business, PDS Biotechnology has no approved products and generates no product revenue; it funds operations primarily through equity financings, collaborations, and grant support. It operates as a single reportable segment and conducts research and development principally in the United States.
26GF Score

Get the complete analysis for FRA:EU6

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.70
Price